Process View
The process in which a relatively unspecialized cell acquires specialized features of a melanocyte.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "melanocyte differentiation"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
HDAC2 | histone deacetylase 2 | 0.734 | ||
BCL2L1 | BCL2-like 1 | 0.643 | ||
EP300 | E1A binding protein p300 | 0.527 | ||
RAB27A | RAB27A, member RAS oncogene family | 0.331 | Mouse | |
POU5F1 | POU class 5 homeobox 1 | 0.325 | ||
PAX3 | paired box 3 | 0.316 | ||
POU3F2 | POU class 3 homeobox 2 | 0.136 | ||
YY1 | YY1 transcription factor | 0.134 | ||
ESR1 | estrogen receptor 1 | 0.120 | ||
FLNB | filamin B, beta | 0.117 | ||
MLPH | melanophilin | 0.116 | Mouse | |
APH1A | anterior pharynx defective 1 homolog A (C. elegans) | 0.106 | ||
BLOC1S1 | biogenesis of lysosomal organelles complex-1, subunit 1 | 0.102 | ||
SIN3A | SIN3 homolog A, transcription regulator (yeast) | 0.099 | ||
SMAD4 | SMAD family member 4 | 0.093 | ||
BLOC1S2 | biogenesis of lysosomal organelles complex-1, subunit 2 | 0.081 | ||
KITLG | KIT ligand | 0.079 | Mouse | |
BAZ2B | bromodomain adjacent to zinc finger domain, 2B | 0.076 | ||
ARRB1 | arrestin, beta 1 | 0.067 | ||
KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | 0.065 | Zebrafish Mouse | |
DTNBP1 | dystrobrevin binding protein 1 | 0.064 | ||
SF3B14 | splicing factor 3B, 14 kDa subunit | 0.056 | ||
TFAP2A | transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) | 0.053 | Zebrafish | |
MUTED | muted homolog (mouse) | 0.052 | ||
MTA3 | metastasis associated 1 family, member 3 | 0.048 | ||
MEOX2 | mesenchyme homeobox 2 | 0.043 | ||
TFAP2C | transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma) | 0.039 | ||
UBE2I | ubiquitin-conjugating enzyme E2I (UBC9 homolog, yeast) | 0.037 | ||
WWP2 | WW domain containing E3 ubiquitin protein ligase 2 | 0.035 | ||
MYO5A | myosin VA (heavy chain 12, myoxin) | 0.035 | Mouse | |
MAP3K1 | mitogen-activated protein kinase kinase kinase 1 | 0.033 | ||
RBBP4 | retinoblastoma binding protein 4 | 0.032 | ||
TCF4 | transcription factor 4 | 0.032 | ||
EPS15 | epidermal growth factor receptor pathway substrate 15 | 0.032 | ||
CITED2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | 0.031 | Human | |
BLOC1S3 | biogenesis of lysosomal organelles complex-1, subunit 3 | 0.031 | ||
DYRK1A | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A | 0.031 | ||
RBM17 | RNA binding motif protein 17 | 0.031 | ||
TGIF1 | TGFB-induced factor homeobox 1 | 0.030 | ||
AGGF1 | angiogenic factor with G patch and FHA domains 1 | 0.029 | ||
STK36 | serine/threonine kinase 36 | 0.029 | ||
EPAS1 | endothelial PAS domain protein 1 | 0.029 | ||
MTA2 | metastasis associated 1 family, member 2 | 0.028 | ||
PML | promyelocytic leukemia | 0.028 | ||
SMAD1 | SMAD family member 1 | 0.027 | ||
MEF2A | myocyte enhancer factor 2A | 0.025 | ||
MECP2 | methyl CpG binding protein 2 (Rett syndrome) | 0.025 | ||
REL | v-rel reticuloendotheliosis viral oncogene homolog (avian) | 0.024 | ||
HDAC4 | histone deacetylase 4 | 0.024 | ||
MARCKS | myristoylated alanine-rich protein kinase C substrate | 0.023 | ||
CIB1 | calcium and integrin binding 1 (calmyrin) | 0.023 | ||
SNAPIN | SNAP-associated protein | 0.023 | ||
SPTBN1 | spectrin, beta, non-erythrocytic 1 | 0.023 | ||
SOX2 | SRY (sex determining region Y)-box 2 | 0.023 | ||
SRI | sorcin | 0.022 | ||
KCTD1 | potassium channel tetramerisation domain containing 1 | 0.022 | ||
NRIP1 | nuclear receptor interacting protein 1 | 0.022 | ||
TRIM32 | tripartite motif containing 32 | 0.021 | ||
BECN1 | beclin 1, autophagy related | 0.021 | ||
RIC8A | resistance to inhibitors of cholinesterase 8 homolog A (C. elegans) | 0.020 | ||
MBD2 | methyl-CpG binding domain protein 2 | 0.020 | ||
BCAS2 | breast carcinoma amplified sequence 2 | 0.020 | ||
NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.019 | ||
TRIM8 | tripartite motif containing 8 | 0.019 | ||
AMBRA1 | autophagy/beclin-1 regulator 1 | 0.019 | ||
PRMT2 | protein arginine methyltransferase 2 | 0.018 | ||
ZFPM1 | zinc finger protein, multitype 1 | 0.017 | ||
SKI | v-ski sarcoma viral oncogene homolog (avian) | 0.017 | ||
AGTR1 | angiotensin II receptor, type 1 | 0.017 | ||
RBBP7 | retinoblastoma binding protein 7 | 0.016 | ||
DNAJB2 | DnaJ (Hsp40) homolog, subfamily B, member 2 | 0.016 | ||
CELF2 | CUGBP, Elav-like family member 2 | 0.016 | ||
CHD4 | chromodomain helicase DNA binding protein 4 | 0.016 | ||
SMARCA2 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 | 0.016 | ||
FHL2 | four and a half LIM domains 2 | 0.016 | ||
DNMT3B | DNA (cytosine-5-)-methyltransferase 3 beta | 0.016 | ||
MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | 0.015 | ||
PPT1 | palmitoyl-protein thioesterase 1 | 0.015 | ||
PMP22 | peripheral myelin protein 22 | 0.015 | ||
PROX1 | prospero homeobox 1 | 0.014 | ||
HIC1 | hypermethylated in cancer 1 | 0.014 | ||
PLRG1 | pleiotropic regulator 1 (PRL1 homolog, Arabidopsis) | 0.014 | ||
WSB1 | WD repeat and SOCS box containing 1 | 0.014 | ||
BIK | BCL2-interacting killer (apoptosis-inducing) | 0.014 | ||
DPYSL2 | dihydropyrimidinase-like 2 | 0.013 | ||
SUGP1 | SURP and G patch domain containing 1 | 0.013 | ||
SH3BP4 | SH3-domain binding protein 4 | 0.013 | ||
MBD3 | methyl-CpG binding domain protein 3 | 0.013 | ||
PPP3R1 | protein phosphatase 3, regulatory subunit B, alpha | 0.013 | ||
UBE2Z | ubiquitin-conjugating enzyme E2Z | 0.013 | ||
GATAD2B | GATA zinc finger domain containing 2B | 0.013 | ||
EXOC8 | exocyst complex component 8 | 0.012 | ||
ATXN3 | ataxin 3 | 0.012 | ||
HEMGN | hemogen | 0.012 | ||
AHR | aryl hydrocarbon receptor | 0.012 | ||
MNAT1 | menage a trois homolog 1, cyclin H assembly factor (Xenopus laevis) | 0.012 | ||
HK2 | hexokinase 2 | 0.012 | ||
PPP2R2A | protein phosphatase 2, regulatory subunit B, alpha | 0.012 | ||
CWC15 | CWC15 spliceosome-associated protein homolog (S. cerevisiae) | 0.012 | ||
CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.012 | ||
NCSTN | nicastrin | 0.012 | ||
NFIC | nuclear factor I/C (CCAAT-binding transcription factor) | 0.012 | ||
AP1S2 | adaptor-related protein complex 1, sigma 2 subunit | 0.011 | ||
BAX | BCL2-associated X protein | 0.011 | ||
CCNH | cyclin H | 0.011 | ||
PPM1D | protein phosphatase, Mg2+/Mn2+ dependent, 1D | 0.011 | ||
HDAC3 | histone deacetylase 3 | 0.011 | ||
TSG101 | tumor susceptibility gene 101 | 0.011 | ||
CNO | cappuccino homolog (mouse) | 0.011 | ||
MUL1 | mitochondrial E3 ubiquitin protein ligase 1 | 0.011 | ||
TOP1 | topoisomerase (DNA) I | 0.011 | ||
MYLK2 | myosin light chain kinase 2 | 0.010 | ||
C14orf43 | chromosome 14 open reading frame 43 | 0.010 | ||
RCOR1 | REST corepressor 1 | 0.010 | ||
FUNDC2 | FUN14 domain containing 2 | 0.010 | ||
LEF1 | lymphoid enhancer-binding factor 1 | 0.010 | ||
DEDD | death effector domain containing | 0.010 | ||
ZBTB4 | zinc finger and BTB domain containing 4 | 0.010 | ||
TMCO6 | transmembrane and coiled-coil domains 6 | 0.010 | ||
BNIP3L | BCL2/adenovirus E1B 19kDa interacting protein 3-like | 0.010 | ||
PRKACB | protein kinase, cAMP-dependent, catalytic, beta | 0.010 | ||
PLA2G16 | phospholipase A2, group XVI | 0.010 | ||
TCF7L2 | transcription factor 7-like 2 (T-cell specific, HMG-box) | 0.010 |